Camolyn, Fisiolin drops recalled
This article was originally published in The Tan Sheet
Executive SummaryU.S. Ofthalmi recalls certain lots of 15 mL bottles of OTC Camolyn eye drops and Fisiolin nasal drops nationwide because it cannot guarantee product sterility. The Hallandale, Fla., firm said non-sterile products can cause infection, and while the chances of a serious adverse reaction are "remote," the company "is taking a conservative approach," according to an April 7 FDA release No adverse effects have been reported. The firm withdraws lots of Camolyn Homeopathic, Camolyn Plus, Naphazoline + Chamomile 15 mL, Camolyn Refresh 15 mL, Camolyn-A, Naphazoline + Pheniramine 15 mL and Fisiolin Nasal Drops Sodium Chloride Pediatric Uses 15 mL
You may also be interested in...
Parliamentary debate next week on the post-Brexit regulatory adjustments ahead for the UK medical devices industry will coincide with the opening of post-Brexit EU trade talks by the UK government. After a period of nervous calm, Brexit will be back with a bang.
Europe’s Innovative Medicines Initiative is to get €90m in funding for programs targeting the coronavirus outbreak.